𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate

✍ Scribed by Yoshinobu Koyama; Hirokazu Shiraishi; Toshiyuki Ohta; Ayumi Uchino

Publisher
Springer
Year
2011
Tongue
English
Weight
350 KB
Volume
22
Category
Article
ISSN
1439-7595

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Interleukin-6 receptor inhibition with t
Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study
✍ Mark C. Genovese; James D. McKay; Evgeny L. Nasonov; Eduardo F. Mysler; Nilzio A πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 148 KB πŸ‘ 2 views
Five-year followup of rheumatoid arthrit
Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year
✍ Suzan M. M. Verstappen; Johannes W. G. Jacobs; Johannes W. J. Bijlsma; Anton H. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 2 views

## Abstract ## Objective To evaluate whether the clinical advantages observed after 1 year in a randomized controlled clinical trial, in which 2 treatment strategies were compared (the early disease‐modifying antirheumatic drug [DMARD] approach versus the pyramid approach), persist after 5 years.